How to trigger a killer: Modulation of natural killer cell reactivity on many levels

Advances in Immunology

Volumn 124, Issue , 2014, Pages 137-170

  Watzl, Carsten ^a  

^a LEIBNIZ RESEARCH CENTRE FOR WORKING ENVIRONMENT AND HUMAN FACTORS   (Germany)

Author keywords

Cytokines; Cytomegalovirus; Cytotoxicity; Immunological memory; Natural Killer cells; NK cell development; Signal transduction; Surface receptors

Indexed keywords

KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; NATURAL KILLER CELL RECEPTOR; NATURAL KILLER CELL RECEPTOR NKG2D; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN DNAM 1; PROTEIN NKP65; PROTEIN NKP80; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG; CYTOKINE; TUMOR ANTIGEN; VIRUS ANTIGEN;

ANTIGEN SPECIFICITY; ARTICLE; CELL MEDIATED CYTOTOXICITY; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; CYTOMEGALOVIRUS INFECTION; HUMAN; IMMUNOMODULATION; IMMUNOREACTIVITY; LYMPHOCYTE FUNCTION; MEMORY CELL; MOLECULAR RECOGNITION; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN MOTIF; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; ANIMAL; CYTOTOXICITY; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIGENS, NEOPLASM; ANTIGENS, VIRAL; CYTOKINES; CYTOTOXICITY, IMMUNOLOGIC; HUMANS; IMMUNOLOGIC MEMORY; IMMUNOMODULATION; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; RECEPTORS, NATURAL KILLER CELL; SIGNAL TRANSDUCTION;

EID: 84906772735     PISSN: 00652776     EISSN: 15578445     Source Type: Book Series    
DOI: 10.1016/B978-0-12-800147-9.00005-4     Document Type: Chapter

References (155)

1. Abeyweera T.P., Merino E., Huse M. Inhibitory signaling blocks activating receptor clustering and induces cytoskeletal retraction in natural killer cells. The Journal of Cell Biology 2011, 192:675-690.
2. Anfossi N., Andre P., Guia S., Falk C.S., Roetynck S., Stewart C.A., et al. Human NK cell education by inhibitory receptors for MHC class I. Immunity 2006, 25:331-342.
3. Bartel Y., Bauer B., Steinle A. Modulation of NK cell function by genetically coupled C-type lectin-like receptor/ligand pairs encoded in the human natural killer gene complex. Frontiers in Immunology 2013, 4:362.
4. Baychelier F., Sennepin A., Ermonval M., Dorgham K., Debre P., Vieillard V. Identification of a cellular ligand for the natural cytotoxicity receptor NKp44. Blood 2013, 122:2935-2942.
5. Bellora F., Castriconi R., Dondero A., Carrega P., Mantovani A., Ferlazzo G., et al. Human NK cells and NK receptors. Immunology Letters 2013, [Epub ahead of print]. 10.1016/j.imlet.2013.12.009.
6. Bessoles S., Angelov G.S., Back J., Leclercq G., Vivier E., Held W. Education of murine NK cells requires both cis and trans recognition of MHC class I molecules. The Journal of Immunology 2013, 191:5044-5051.
7. + NK cells expressing self-specific KIRs in chronic hepatitis patients. European Journal of Immunology 2012, 42:447-457.
8. Bezman N.A., Kim C.C., Sun J.C., Min-Oo G., Hendricks D.W., Kamimura Y., et al. Molecular definition of the identity and activation of natural killer cells. Nature Immunology 2012, 13:1000-1009.
9. Bjorkstrom N.K., Lindgren T., Stoltz M., Fauriat C., Braun M., Evander M., et al. Rapid expansion and long-term persistence of elevated NK cell numbers in humans infected with hantavirus. The Journal of Experimental Medicine 2011, 208:13-21.
10. Bottino C., Castriconi R., Pende D., Rivera P., Nanni M., Carnemolla B., et al. Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule. The Journal of Experimental Medicine 2003, 198:557-567.
11. Brandt C.S., Baratin M., Yi E.C., Kennedy J., Gao Z., Fox B., et al. The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans. The Journal of Experimental Medicine 2009, 206:1495-1503.
12. Brodin P., Lakshmikanth T., Johansson S., Karre K., Hoglund P. The strength of inhibitory input during education quantitatively tunes the functional responsiveness of individual natural killer cells. Blood 2009, 113:2434-2441.
13. Bryceson Y.T., Ljunggren H.G., Long E.O. Minimal requirement for induction of natural cytotoxicity and intersection of activation signals by inhibitory receptors. Blood 2009, 114:2657-2666.
14. Bryceson Y.T., March M.E., Ljunggren H.G., Long E.O. Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion. Blood 2006, 107:159-166.
15. Budagian V., Bulanova E., Paus R., Bulfone-Paus S. IL-15/IL-15 receptor biology: A guided tour through an expanding universe. Cytokine and Growth Factor Reviews 2006, 17:259-280.
16. Burshtyn D.N., Shin J., Stebbins C., Long E.O. Adhesion to target cells is disrupted by the killer cell inhibitory receptor. Current Biology 2000, 10:777-780.
17. Campbell K.S., Yusa S.-I., Kikuchi-Maki A., Catina T.L. NKp44 triggers NK cell activation through DAP12 association that is not influenced by a putative cytoplasmic inhibitory sequence. The Journal of Immunology 2004, 172:899-906.
18. Cantoni C., Bottino C., Vitale M., Pessino A., Augugliaro R., Malaspina A., et al. NKp44, a triggering receptor involved in tumor cell lysis by activated human natural killer cells, is a novel member of the immunoglobulin superfamily. The Journal of Experimental Medicine 1999, 189:787-796.
19. Caraux A., Kim N., Bell S.E., Zompi S., Ranson T., Lesjean-Pottier S., et al. Phospholipase C-gamma2 is essential for NK cell cytotoxicity and innate immunity to malignant and virally infected cells. Blood 2006, 107:994-1002.
20. Cella M., Fujikawa K., Tassi I., Kim S., Latinis K., Nishi S., et al. Differential requirements for Vav proteins in DAP10- and ITAM-mediated NK cell cytotoxicity. The Journal of Experimental Medicine 2004, 200:817-823.
21. Chalifour A., Scarpellino L., Back J., Brodin P., Devevre E., Gros F., et al. A role for cis interaction between the inhibitory Ly49A receptor and MHC class I for natural killer cell education. Immunity 2009, 30:337-347.
22. Chan G., Hanke T., Fischer K.D. Vav-1 regulates NK T cell development and NK cell cytotoxicity. European Journal of Immunology 2001, 31:2403-2410.
23. Chlewicki L.K., Velikovsky C.A., Balakrishnan V., Mariuzza R.A., Kumar V. Molecular basis of the dual functions of 2B4 (CD244). The Journal of Immunology 2008, 180:8159-8167.
24. Claus M., Meinke S., Bhat R., Watzl C. Regulation of NK cell activity by 2B4, NTB-A and CRACC. Frontiers in Bioscience 2008, 13:956-965.
25. Colucci F., Rosmaraki E., Bregenholt S., Samson S.I., Di Bartolo V., Turner M., et al. Functional dichotomy in natural killer cell signaling: Vav1-dependent and -independent mechanisms. The Journal of Experimental Medicine 2001, 193:1413-1424.
26. Colucci F., Schweighoffer E., Tomasello E., Turner M., Ortaldo J.R., Vivier E., et al. Natural cytotoxicity uncoupled from the Syk and ZAP-70 intracellular kinases. Nature Immunology 2002, 3:288-294.
27. Cooper M.A., Colonna M., Yokoyama W.M. Hidden talents of natural killers: NK cells in innate and adaptive immunity. EMBO Reports 2009, 10:1103-1110.
28. Cooper M.A., Elliott J.M., Keyel P.A., Yang L., Carrero J.A., Yokoyama W.M. Cytokine-induced memory-like natural killer cells. Proceedings of the National Academy of Sciences of the United States of America 2009, 106:1915-1919.
29. Cruz-Munoz M.E., Dong Z., Shi X., Zhang S., Veillette A. Influence of CRACC, a SLAM family receptor coupled to the adaptor EAT-2, on natural killer cell function. Nature Immunology 2009, 10:297-305.
30. Davidson D., Shi X., Zhang S., Wang H., Nemer M., Ono N., et al. Genetic evidence linking SAP, the X-linked lymphoproliferative gene product, to Src-related kinase FynT in T(H)2 cytokine regulation. Immunity 2004, 21:707-717.
31. Davis D.M., Chiu I., Fassett M., Cohen G.B., Mandelboim O., Strominger J.L. The human natural killer cell immune synapse. Proceedings of the National Academy of Sciences of the United States of America 1999, 96:15062-15067.
32. Delahaye N.F., Rusakiewicz S., Martins I., Menard C., Roux S., Lyonnet L., et al. Alternatively spliced NKp30 isoforms affect the prognosis of gastrointestinal stromal tumors. Nature Medicine 2011, 17:700-707.
33. Della Chiesa M., Falco M., Bertaina A., Muccio L., Alicata C., Frassoni F., et al. Human cytomegalovirus infection promotes rapid maturation of NK cells expressing activating killer Ig-like receptor in patients transplanted with NKG2C-/- umbilical cord blood. The Journal of Immunology 2014, 192:1471-1479.
34. Dennehy K.M., Klimosch S.N., Steinle A. Cutting edge: NKp80 uses an atypical hemi-ITAM to trigger NK cytotoxicity. The Journal of Immunology 2011, 186:657-661.
35. Dokun A.O., Kim S., Smith H.R., Kang H.S., Chu D.T., Yokoyama W.M. Specific and nonspecific NK cell activation during virus infection. Nature Immunology 2001, 2:951-956.
36. Dong Z., Davidson D., Perez-Quintero L.A., Kurosaki T., Swat W., Veillette A. The adaptor SAP controls NK cell activation by regulating the enzymes Vav-1 and SHIP-1 and by enhancing conjugates with target cells. Immunity 2012, 36:974-985.
37. Doucey M.A., Scarpellino L., Zimmer J., Guillaume P., Luescher I.F., Bron C., et al. Cis association of Ly49A with MHC class I restricts natural killer cell inhibition. Nature Immunology 2004, 5:328-336.
38. Ebihara T., Jonsson A.H., Yokoyama W.M. Natural killer cell licensing in mice with inducible expression of MHC class I. Proceedings of the National Academy of Sciences of the United States of America 2013, 110:E4232-E4237.
39. Eissmann P., Beauchamp L., Wooters J., Tilton J.C., Long E.O., Watzl C. Molecular basis for positive and negative signaling by the natural killer cell receptor 2B4 (CD244). Blood 2005, 105:4722-4729.
40. Elliott J.M., Wahle J.A., Yokoyama W.M. MHC class I-deficient natural killer cells acquire a licensed phenotype after transfer into an MHC class I-sufficient environment. The Journal of Experimental Medicine 2010, 207:2073-2079.
41. Endt J., Eissmann P., Hoffmann S.C., Meinke S., Giese T., Watzl C. Modulation of 2B4 (CD244) activity and regulated SAP expression in human NK cells. European Journal of Immunology 2007, 37:193-198.
42. Endt J., McCann F.E., Almeida C.R., Urlaub D., Leung R., Pende D., et al. Inhibitory receptor signals suppress ligation-induced recruitment of NKG2D to GM1-rich membrane domains at the human NK cell immune synapse. The Journal of Immunology 2007, 178:5606-5611.
43. Eriksson M., Leitz G., Fallman E., Axner O., Ryan J.C., Nakamura M.C., et al. Inhibitory receptors alter natural killer cell interactions with target cells yet allow simultaneous killing of susceptible targets. The Journal of Experimental Medicine 1999, 190:1005-1012.
44. Falco M., Marcenaro E., Romeo E., Bellora F., Marras D., Vely F., et al. Homophilic interaction of NTBA, a member of the CD2 molecular family: Induction of cytotoxicity and cytokine release in human NK cells. European Journal of Immunology 2004, 34:1663-1672.
45. Fehniger T.A., Cai S.F., Cao X., Bredemeyer A.J., Presti R.M., French A.R., et al. Acquisition of murine NK cell cytotoxicity requires the translation of a pre-existing pool of granzyme B and perforin mRNAs. Immunity 2007, 26:798-811.
46. Fernandez N.C., Treiner E., Vance R.E., Jamieson A.M., Lemieux S., Raulet D.H. A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules. Blood 2005, 105:4416-4423.
47. Flaig R.M., Stark S., Watzl C. Cutting edge: NTB-A activates NK cells via homophilic interaction. The Journal of Immunology 2004, 172:6524-6527.
48. Ganal S.C., Sanos S.L., Kallfass C., Oberle K., Johner C., Kirschning C., et al. Priming of natural killer cells by nonmucosal mononuclear phagocytes requires instructive signals from commensal microbiota. Immunity 2012, 37:171-186.
49. Garni-Wagner B.A., Purohit A., Mathew P.A., Bennett M., Kumar V. A novel function-associated molecule related to non-MHC-restricted cytotoxicity mediated by activated natural killer cells and T cells. The Journal of Immunology 1993, 151:60-70.
50. Gillard G.O., Bivas-Benita M., Hovav A.H., Grandpre L.E., Panas M.W., Seaman M.S., et al. Thy1+ NK [corrected] cells from vaccinia virus-primed mice confer protection against vaccinia virus challenge in the absence of adaptive lymphocytes. PLoS Pathogens 2011, 7:e1002141.
51. Guia S., Jaeger B.N., Piatek S., Mailfert S., Trombik T., Fenis A., et al. Confinement of activating receptors at the plasma membrane controls natural killer cell tolerance. Science Signaling 2011, 4:ra21.
52. Guma M., Budt M., Saez A., Brckalo T., Hengel H., Angulo A., et al. Expansion of CD94/NKG2C+ NK cells in response to human cytomegalovirus-infected fibroblasts. Blood 2006, 107:3624-3631.
53. Ham H., Billadeau D.D. Human immunodeficiency syndromes affecting human natural killer cell cytolytic activity. Frontiers in Immunology 2014, 5:2.
54. Held W., Dorfman J.R., Wu M.F., Raulet D.H. Major histocompatibility complex class I-dependent skewing of the natural killer cell Ly49 receptor repertoire. European Journal of Immunology 1996, 26:2286-2292.
55. Held W., Raulet D.H. Ly49A transgenic mice provide evidence for a major histocompatibility complex-dependent education process in natural killer cell development. The Journal of Experimental Medicine 1997, 185:2079-2088.
56. Herberman R.B., Nunn M.E., Lavrin D.H. Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic acid allogeneic tumors. I. Distribution of reactivity and specificity. International Journal of Cancer 1975, 16:216-229.
57. Hoglund P., Ohlen C., Carbone E., Franksson L., Ljunggren H.G., Latour A., et al. Recognition of beta 2-microglobulin-negative (beta 2m-) T-cell blasts by natural killer cells from normal but not from beta 2m- mice: Nonresponsiveness controlled by beta 2m- bone marrow in chimeric mice. Proceedings of the National Academy of Sciences of the United States of America 1991, 88:10332-10336.
58. Horowitz A., Strauss-Albee D.M., Leipold M., Kubo J., Nemat-Gorgani N., Dogan O.C., et al. Genetic and environmental determinants of human NK cell diversity revealed by mass cytometry. Science Translational Medicine 2013, 5:208ra145.
59. Horton N.C., Mathew S.O., Mathew P.A. Novel interaction between proliferating cell nuclear antigen and HLA I on the surface of tumor cells inhibits NK cell function through NKp44. PLoS One 2013, 8:e59552.
60. Imai K., Matsuyama S., Miyake S., Suga K., Nakachi K. Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence: An 11-year follow-up study of a general population. Lancet 2000, 356:1795-1799.
61. Jacobi C., Claus M., Wildemann B., Wingert S., Korporal M., Romisch J., et al. Exposure of NK cells to intravenous immunoglobulin induces IFN gamma release and degranulation but inhibits their cytotoxic activity. Clinical Immunology 2009, 133:393-401.
62. Jiang K., Zhong B., Gilvary D.L., Corliss B.C., Hong-Geller E., Wei S., et al. Pivotal role of phosphoinositide-3 kinase in regulation of cytotoxicity in natural killer cells. Nature Immunology 2000, 1:419-425.
63. Joncker N.T., Fernandez N.C., Treiner E., Vivier E., Raulet D.H. NK cell responsiveness is tuned commensurate with the number of inhibitory receptors for self-MHC class I: The rheostat model. The Journal of Immunology 2009, 182:4572-4580.
64. Joncker N.T., Shifrin N., Delebecque F., Raulet D.H. Mature natural killer cells reset their responsiveness when exposed to an altered MHC environment. The Journal of Experimental Medicine 2010, 207:2065-2072.
65. Jost S., Altfeld M. Control of human viral infections by natural killer cells. Annual Review of Immunology 2013, 31:163-194.
66. Karre K. How to recognize a foreign submarine. Immunology Reviews 1997, 155:5-9.
67. Kelley J., Walter L., Trowsdale J. Comparative genomics of natural killer cell receptor gene clusters. PLoS Genetics 2005, 1:129-139.
68. Kiessling R., Klein E., Wigzell H. "Natural" killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype. European Journal of Immunology 1975, 5:112-117.
69. Kim H.S., Das A., Gross C.C., Bryceson Y.T., Long E.O. Synergistic signals for natural cytotoxicity are required to overcome inhibition by c-Cbl ubiquitin ligase. Immunity 2010, 32:175-186.
70. Kim H.S., Long E.O. Complementary phosphorylation sites in the adaptor protein SLP-76 promote synergistic activation of natural killer cells. Science Signaling 2012, 5:ra49.
71. Kim S., Poursine-Laurent J., Truscott S.M., Lybarger L., Song Y.J., Yang L., et al. Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature 2005, 436:709-713.
72. Klimosch S.N., Bartel Y., Wiemann S., Steinle A. Genetically coupled receptor-ligand pair NKp80-AICL enables autonomous control of human NK cell responses. Blood 2013, 122:2380-2389.
73. Kobayashi H., Dubois S., Sato N., Sabzevari H., Sakai Y., Waldmann T.A., et al. Role of trans-cellular IL-15 presentation in the activation of NK cell-mediated killing, which leads to enhanced tumor immunosurveillance. Blood 2005, 105:721-727.
74. Koch J., Steinle A., Watzl C., Mandelboim O. Activating natural cytotoxicity receptors of natural killer cells in cancer and infection. Trends in Immunology 2013, 34:182-191.
75. Kruse P.H., Matta J., Ugolini S., Vivier E. Natural cytotoxicity receptors and their ligands. Immunology and Cell Biology 2013, 92:221-229.
76. Kumaresan P.R., Lai W.C., Chuang S.S., Bennett M., Mathew P.A. CS1, a novel member of the CD2 family, is homophilic and regulates NK cell function. Molecular Immunology 2002, 39:1-8.
77. Kurosaki T., Gander I., Ravetch J.V. A subunit common to an IgG Fc receptor and the T-cell receptor mediates assembly through different interactions. Proceedings of the National Academy of Sciences of the United States of America 1991, 88:3837-3841.
78. Lee J.E., Lim S.A., Kim T.-J., Kim K., Ng J., Kim Y.H., et al. NKG2D ligation relieves 2B4-mediated NK-cell self-tolerance in mice. European Journal of Immunology 2014, 44(6):1802-1813.
79. Leong J.W., Chase J.M., Romee R., Schneider S.E., Sullivan R.P., Cooper M.A., et al. Preactivation with IL-12, IL-15, and IL-18 induces CD25 and a functional high-affinity IL-2 receptor on human cytokine-induced memory-like natural killer cells. Biology of Blood and Marrow Transplantations 2014, 20(4):463-473.
80. Liao N.S., Bix M., Zijlstra M., Jaenisch R., Raulet D. MHC class I deficiency: Susceptibility to natural killer (NK) cells and impaired NK activity. Science 1991, 253:199-202.
81. Lingwood D., Simons K. Lipid rafts as a membrane-organizing principle. Science 2010, 327:46-50.
82. Liu D., Peterson M.E., Long E.O. The adaptor protein Crk controls activation and inhibition of natural killer cells. Immunity 2012, 36:600-611.
83. Long E.O., Barber D.F., Burshtyn D.N., Faure M., Peterson M., Rajagopalan S., et al. Inhibition of natural killer cell activation signals by killer cell immunoglobulin-like receptors (CD158). Immunology Reviews 2001, 181:223-233.
84. Long E.O., Kim H.S., Liu D., Peterson M.E., Rajagopalan S. Controlling natural killer cell responses: Integration of signals for activation and inhibition. Annual Review of Immunology 2013, 31:227-258.
85. Lopez-Verges S., Milush J.M., Schwartz B.S., Pando M.J., Jarjoura J., York V.A., et al. Expansion of a unique CD57(+)NKG2Chi natural killer cell subset during acute human cytomegalovirus infection. Proceedings of the National Academy of Sciences of the United States of America 2011, 108:14725-14732.
86. Lou Z., Jevremovic D., Billadeau D.D., Leibson P.J. A balance between positive and negative signals in cytotoxic lymphocytes regulates the polarization of lipid rafts during the development of cell-mediated killing. The Journal of Experimental Medicine 2000, 191:347-354.
87. Lucas M., Schachterle W., Oberle K., Aichele P., Diefenbach A. Dendritic cells prime natural killer cells by trans-presenting interleukin 15. Immunity 2007, 26:503-517.
88. Majewska-Szczepanik M., Paust S., von Andrian U.H., Askenase P.W., Szczepanik M. Natural killer cell-mediated contact sensitivity develops rapidly and depends on interferon-alpha, interferon-gamma and interleukin-12. Immunology 2013, 140:98-110.
89. Marcus A., Gowen B.G., Thompson T.W., Iannello A., Ardolino M., Deng W., et al. Recognition of tumors by the innate immune system and natural killer cells. Advances in Immunology 2014, 122:91-128.
90. Mason L.H., Willette-Brown J., Taylor L.S., McVicar D.W. Regulation of Ly49D/DAP12 signal transduction by Src-family kinases and CD45. The Journal of Immunology 2006, 176:6615-6623.
91. Maul-Pavicic A., Chiang S.C., Rensing-Ehl A., Jessen B., Fauriat C., Wood S.M., et al. ORAI1-mediated calcium influx is required for human cytotoxic lymphocyte degranulation and target cell lysis. Proceedings of the National Academy of Sciences of the United States of America 2011, 108:3324-3329.
92. Meazza R., Tuberosa C., Cetica V., Falco M., Loiacono F., Parolini S., et al. XLP1 inhibitory effect by 2B4 does not affect DNAM-1 and NKG2D activating pathways in NK cells. European Journal of Immunology 2014, 44(5):1526-1534.
93. Meinke S., Watzl C. NK cell cytotoxicity mediated by 2B4 and NTB-A is dependent on SAP acting downstream of receptor phosphorylation. Frontiers in Immunology 2013, 4:3.
94. Mesecke S., Urlaub D., Busch H., Eils R., Watzl C. Integration of activating and inhibitory receptor signaling by regulated phosphorylation of Vav1 in immune cells. Science Signaling 2011, 4:ra36.
95. Messmer B., Eissmann P., Stark S., Watzl C. CD48 stimulation by 2B4 (CD244)-expressing targets activates human NK cells. The Journal of Immunology 2006, 176:4646-4650.
96. Min-Oo G., Kamimura Y., Hendricks D.W., Nabekura T., Lanier L.L. Natural killer cells: Walking three paths down memory lane. Trends in Immunology 2013, 34:251-258.
97. Mortier E., Woo T., Advincula R., Gozalo S., Ma A. IL-15Ralpha chaperones IL-15 to stable dendritic cell membrane complexes that activate NK cells via trans presentation. The Journal of Experimental Medicine 2008, 205:1213-1225.
98. Mrozek E., Anderson P., Caligiuri M.A. Role of interleukin-15 in the development of human CD56+ natural killer cells from CD34+ hematopoietic progenitor cells. Blood 1996, 87:2632-2640.
99. Muntasell A., Vilches C., Angulo A., Lopez-Botet M. Adaptive reconfiguration of the human NK-cell compartment in response to cytomegalovirus: A different perspective of the host-pathogen interaction. European Journal of Immunology 2013, 43:1133-1141.
100. Nabekura T., Kanaya M., Shibuya A., Fu G., Gascoigne N.R., Lanier L.L. Costimulatory molecule DNAM-1 is essential for optimal differentiation of memory natural killer cells during mouse cytomegalovirus infection. Immunity 2014, 40:225-234.
101. Nakajima H., Cella M., Bouchon A., Grierson H.L., Lewis J., Duckett C.S., et al. Patients with X-linked lymphoproliferative disease have a defect in 2B4 receptor-mediated NK cell cytotoxicity. European Journal of Immunology 2000, 30:3309-3318.
102. Neville M.J., Campbell R.D. A new member of the Ig superfamily and a V-ATPase G subunit are among the predicted products of novel genes close to the TNF locus in the human MHC. Journal of Immunology 1999, 162:4745-4754.
103. Ni J., Miller M., Stojanovic A., Cerwenka A. Toward the next generation of NK cell-based adoptive cancer immunotherapy. Oncoimmunology 2013, 2:e23811.
104. Ni J., Miller M., Stojanovic A., Garbi N., Cerwenka A. Sustained effector function of IL-12/15/18-preactivated NK cells against established tumors. The Journal of Experimental Medicine 2012, 209:2351-2365.
105. O'Leary J.G., Goodarzi M., Drayton D.L., von Andrian U.H. T cell- and B cell-independent adaptive immunity mediated by natural killer cells. Nature Immunology 2006, 7:507-516.
106. Ombrello M.J., Remmers E.F., Sun G., Freeman A.F., Datta S., Torabi-Parizi P., et al. Cold urticaria, immunodeficiency, and autoimmunity related to PLCG2 deletions. The New England Journal of Medicine 2012, 366:330-338.
107. Orange J.S. Natural killer cell deficiency. The Journal of Allergy and Clinical Immunology 2013, 132:515-525. quiz 526.
108. Orr M.T., Lanier L.L. Natural killer cell education and tolerance. Cell 2010, 142:847-856.
109. Orr M.T., Murphy W.J., Lanier L.L. 'Unlicensed' natural killer cells dominate the response to cytomegalovirus infection. Nature Immunology 2010, 11:321-327.
110. Parolini S., Bottino C., Falco M., Augugliaro R., Giliani S., Franceschini R., et al. X-linked lymphoproliferative disease. 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein-Barr virus-infected cells. The Journal of Experimental Medicine 2000, 192:337-346.
111. Paust S., Gill H.S., Wang B.Z., Flynn M.P., Moseman E.A., Senman B., et al. Critical role for the chemokine receptor CXCR6 in NK cell-mediated antigen-specific memory of haptens and viruses. Nature Immunology 2010, 11:1127-1135.
112. Paust S., von Andrian U.H. Natural killer cell memory. Nature Immunology 2011, 12:500-508.
113. Peng H., Jiang X., Chen Y., Sojka D.K., Wei H., Gao X., et al. Liver-resident NK cells confer adaptive immunity in skin-contact inflammation. The Journal of Clinical Investigation 2013, 123:1444-1456.
114. Peterson M.E., Long E.O. Inhibitory receptor signaling via tyrosine phosphorylation of the adaptor Crk. Immunity 2008, 29:578-588.
115. Pogge von Strandmann E., Simhadri V.R., von Tresckow B., Sasse S., Reiners K.S., Hansen H.P., et al. Human leukocyte antigen-B-associated transcript 3 is released from tumor cells and engages the NKp30 receptor on natural killer cells. Immunity 2007, 27:965-974.
116. Rajasekaran K., Kumar P., Schuldt K.M., Peterson E.J., Vanhaesebroeck B., Dixit V., et al. Signaling by Fyn-ADAP via the Carma1-Bcl-10-MAP3K7 signalosome exclusively regulates inflammatory cytokine production in NK cells. Nature Immunology 2013, 14:1127-1136.
117. Raulet D.H., Gasser S., Gowen B.G., Deng W., Jung H. Regulation of ligands for the NKG2D activating receptor. Annual Review of Immunology 2013, 31:413-441.
118. Romee R., Schneider S.E., Leong J.W., Chase J.M., Keppel C.R., Sullivan R.P., et al. Cytokine activation induces human memory-like NK cells. Blood 2012, 120:4751-4760.
119. Rosental B., Brusilovsky M., Hadad U., Oz D., Appel M.Y., Afergan F., et al. Proliferating cell nuclear antigen is a novel inhibitory ligand for the natural cytotoxicity receptor NKp44. The Journal of Immunology 2011, 187:5693-5702.
120. Roussev R.G., Ng S.C., Coulam C.B. Natural killer cell functional activity suppression by intravenous immunoglobulin, intralipid and soluble human leukocyte antigen-G. American Journal of Reproductive Immunology 2007, 57:262-269.
121. Shibuya A., Lanier L.L., Phillips J.H. Protein kinase C is involved in the regulation of both signaling and adhesion mediated by DNAX accessory molecule-1 receptor. The Journal of Immunology 1998, 161:1671-1676.
122. Shibuya K., Lanier L.L., Phillips J.H., Ochs H.D., Shimizu K., Nakayama E., et al. Physical and functional association of LFA-1 with DNAM-1 adhesion molecule. Immunity 1999, 11:615-623.
123. Shirakawa J., Shibuya K., Shibuya A. Requirement of the serine at residue 329 for lipid raft recruitment of DNAM-1 (CD226). International Immunology 2005, 17:217-223.
124. Siberil S., Elluru S., Graff-Dubois S., Negi V.S., Delignat S., Mouthon L., et al. Intravenous immunoglobulins in autoimmune and inflammatory diseases: A mechanistic perspective. The Annals of the New York Academy of Sciences 2007, 1110:497-506.
125. Sivori S., Falco M., Marcenaro E., Parolini S., Biassoni R., Bottino C., et al. Early expression of triggering receptors and regulatory role of 2B4 in human natural killer cell precursors undergoing in vitro differentiation. Proceedings of the National Academy of Sciences of the United States of America 2002, 99:4526-4531.
126. Sivori S., Vitale M., Morelli L., Sanseverino L., Augugliaro R., Bottino C., et al. p46, a novel natural killer cell-specific surface molecule that mediates cell activation. The Journal of Experimental Medicine 1997, 186:1129-1136.
127. Spreu J., Kuttruff S., Stejfova V., Dennehy K.M., Schittek B., Steinle A. Interaction of C-type lectin-like receptors NKp65 and KACL facilitates dedicated immune recognition of human keratinocytes. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:5100-5105.
128. Stebbins C.C., Watzl C., Billadeau D.D., Leibson P.J., Burshtyn D.N., Long E.O. Vav1 dephosphorylation by the tyrosine phosphatase SHP-1 as a mechanism for inhibition of cellular cytotoxicity. Molecular and Cellular Biology 2003, 23:6291-6299.
129. Sun J.C., Beilke J.N., Lanier L.L. Adaptive immune features of natural killer cells. Nature 2009, 457:557-561.
130. Sun J.C., Madera S., Bezman N.A., Beilke J.N., Kaplan M.H., Lanier L.L. Proinflammatory cytokine signaling required for the generation of natural killer cell memory. The Journal of Experimental Medicine 2012, 209:947-954.
131. Sutherland C.L., Chalupny N.J., Schooley K., VandenBos T., Kubin M., Cosman D. UL16-binding proteins, novel MHC class I-related proteins, bind to NKG2D and activate multiple signaling pathways in primary NK cells. The Journal of Immunology 2002, 168:671-679.
132. Tangye S.G., Phillips J.H., Lanier L.L., Nichols K.E. Functional requirement for SAP in 2B4-mediated activation of human natural killer cells as revealed by the X-linked lymphoproliferative syndrome. The Journal of Immunology 2000, 165:2932-2936.
133. Tarek N., Le Luduec J.B., Gallagher M.M., Zheng J., Venstrom J.M., Chamberlain E., et al. Unlicensed NK cells target neuroblastoma following anti-GD2 antibody treatment. The Journal of Clinical Investigation 2012, 122:3260-3270.
134. Tassi I., Presti R., Kim S., Yokoyama W.M., Gilfillan S., Colonna M. Phospholipase C-gamma 2 is a critical signaling mediator for murine NK cell activating receptors. The Journal of Immunology 2005, 175:749-754.
135. Tha-In T., Metselaar H.J., Tilanus H.W., Groothuismink Z.M., Kuipers E.J., de Man R.A., et al. Intravenous immunoglobulins suppress T-cell priming by modulating the bidirectional interaction between dendritic cells and natural killer cells. Blood 2007, 110:3253-3262.
136. Thomas L.M., Peterson M.E., Long E.O. Cutting edge: NK cell licensing modulates adhesion to target cells. The Journal of Immunology 2013, 191:3981-3985.
137. Upshaw J.L., Arneson L.N., Schoon R.A., Dick C.J., Billadeau D.D., Leibson P.J. NKG2D-mediated signaling requires a DAP10-bound Grb2-Vav1 intermediate and phosphatidylinositol-3-kinase in human natural killer cells. Nature Immunology 2006, 7:524-532.
138. Upshaw J.L., Schoon R.A., Dick C.J., Billadeau D.D., Leibson P.J. The isoforms of phospholipase C-gamma are differentially used by distinct human NK activating receptors. The Journal of Immunology 2005, 175:213-218.
139. Valiante N.M., Uhrberg M., Shilling H.G., Lienert-Weidenbach K., Arnett K.L., D'Andrea A., et al. Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors. Immunity 1997, 7:739-751.
140. van Oers N.S., Lowin-Kropf B., Finlay D., Connolly K., Weiss A. alpha beta T cell development is abolished in mice lacking both Lck and Fyn protein tyrosine kinases. Immunity 1996, 5:429-436.
141. Veillette A. SLAM-family receptors: Immune regulators with or without SAP-family adaptors. Cold Spring Harbor Perspectives in Biology 2010, 2:a002469.
142. Vitale M., Bottino C., Sivori S., Sanseverino L., Castriconi R., Marcenaro E., et al. NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysis. The Journal of Experimental Medicine 1998, 187:2065-2072.
143. Vivier E., Raulet D.H., Moretta A., Caligiuri M.A., Zitvogel L., Lanier L.L., et al. Innate or adaptive immunity? The example of natural killer cells. Science 2011, 331:44-49.
144. Vivier E., Tomasello E., Baratin M., Walzer T., Ugolini S. Functions of natural killer cells. Nature Immunology 2008, 9:503-510.
145. Waggoner S.N., Taniguchi R.T., Mathew P.A., Kumar V., Welsh R.M. Absence of mouse 2B4 promotes NK cell-mediated killing of activated CD8+ T cells, leading to prolonged viral persistence and altered pathogenesis. The Journal of Clinical Investigation 2010, 120:1925-1938.
146. Walzer T., Blery M., Chaix J., Fuseri N., Chasson L., Robbins S.H., et al. Identification, activation, and selective in vivo ablation of mouse NK cells via NKp46. Proceedings of the National Academy of Sciences of the United States of America 2007, 104:3384-3389.
147. Watzl C., Long E.O. Natural killer cell inhibitory receptors block actin cytoskeleton-dependent recruitment of 2B4 (CD244) to lipid rafts. The Journal of Experimental Medicine 2003, 197:77-85.
148. Watzl C., Stebbins C.C., Long E.O. NK cell inhibitory receptors prevent tyrosine phosphorylation of the activation receptor 2B4 (CD244). The Journal of Immunology 2000, 165:3545-3548.
149. Watzl C., Urlaub D. Molecular mechanisms of natural killer cell regulation. Frontiers in Bioscience (Landmark Edition) 2012, 17:1418-1432.
150. Welte S., Kuttruff S., Waldhauer I., Steinle A. Mutual activation of natural killer cells and monocytes mediated by NKp80-AICL interaction. Nature Immunology 2006, 7:1334-1342.
151. Westermann J., Pabst R. Distribution of lymphocyte subsets and natural killer cells in the human body. The Clinical Investigator 1992, 70:539-544.
152. Yokoyama W.M., Seaman W.E. The Ly-49 and NKR-P1 gene families encoding lectin-like receptors on natural killer cells: The NK gene complex. Annual Review of Immunology 1993, 11:613-635.
153. Yu J., Freud A.G., Caligiuri M.A. Location and cellular stages of natural killer cell development. Trends in Immunology 2013, 34:573-582.
154. Zanoni I., Spreafico R., Bodio C., Di Gioia M., Cigni C., Broggi A., et al. IL-15 cis presentation is required for optimal NK cell activation in lipopolysaccharide-mediated inflammatory conditions. Cell Reports 2013, 4:1235-1249.
155. Zhang T., Scott J.M., Hwang I., Kim S. Cutting edge: Antibody-dependent memory-like NK cells distinguished by FcRgamma deficiency. The Journal of Immunology 2013, 190:1402-1406.